The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Open accessAbstract
Regulatory T (Treg) cells expressing the transcription factor Foxp3 have a critical role in the maintenance of immune homeostasis and prevention of autoimmunity. Recent advances in single cell analyses have revealed a range of Treg cell activation and differentiation states in different human pathologies. Here we review recent progress in the understanding of human Treg cell heterogeneity and function. We discuss these findings within the context of concepts in Treg cell development and function derived from preclinical models and insight from approaches targeting Treg cells in clinical settings. Distinguishing functional Treg cells from other T cells and understanding the context-dependent function(s) of different Treg subsets will be crucial to the development of strategies toward the selective therapeutic manipulation of Treg cells in autoimmunity and cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These cells exert immunosuppressive effects through multiple mechanisms, including cytokine secretion, metabolic disruption of effector T cells, and modulation of antigen-presenting cells (APCs) (Bilate and Lafaille 2012; Josefowicz et al. 2012; Wing et al. 2019).”
From The double-edged sword of regulatory T cells in MASLD: from inflammation control to fibrosis promotion (2026) · cites this paper as Wing et al. 2019
Citations
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
The Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Park, J., Adoro, S., Guinter, T. I., Erman, B., Alag, A., Catálfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationFreeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Charoentong, P., Finotello, F., Angelova, M., Mayer, C., Efremova, M., Rieder, D., Hackl, H., & Trajanoski, Z. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.019 · Cited by 5,041
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
Dong, H., Strome, S. E., Salomao, D. R., Tamura, H., Hirano, F., Flies, D. B., Roche, P. C., Lu, J., Zhu, G., Tamada, K., et al. (2002) · Nature Medicine · doi:10.1038/nm730 · Cited by 5,025
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M., Ferguson, P., Whitesell, L., Kelly, T., Saulsbury, F., Chance, P., & Ochs, H. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,576
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 730
Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients
Wang, H., Feng, X., Yan, W., & Tian, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575572 · Cited by 57
Immune cellular components and signaling pathways in the tumor microenvironment
Yenyuwadee, S., Aliazis, K., Wang, Q., Christofides, A., Shah, R., Patsoukis, N., & Boussiotis, V. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.08.004 · Cited by 54
Identification and classification of distinct surface markers of T regulatory cells
Węgrzyn, A., Kedzierska, A. E., & Obojski, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1055805 · Cited by 56
Role of Treg cell subsets in cardiovascular disease pathogenesis and potential therapeutic targets
Xia, Y., Gao, D., Wang, X., Liu, B., Shan, X., Sun, Y., & Ma, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1331609 · Cited by 58
Ronin, É., Pouchy, C., Khosravi, M., Hilaire, M., Grégoire, S., Casrouge, A., Kassem, S., Sleurs, D., Martin, G. H., Chanson, N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014043118 · Cited by 62
Watanabe, T., Ishino, T., Ueda, Y., Nagasaki, J., Sadahira, T., Dansako, H., Araki, M., & Togashi, Y. (2023) · Cancer Science · doi:10.1111/cas.15756 · Cited by 53
Wang, Z., Ji, X., Zhang, Y., Yang, F., Su, H., Zhang, H., Li, Z., Zhang, W., & Sun, W. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-008983 · Cited by 54
Role of Epigenetics in the Regulation of Immune Functions of the Skin
Sawada, Y., & Gallo, R. L. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.10.012 · Cited by 53
PD-1+ Treg cells: a foe in cancer immunotherapy?
Aksoylar, H., & Boussiotis, V. A. (2020) · Nature Immunology · doi:10.1038/s41590-020-0801-7 · Cited by 53
Sympathetic nervous tone limits the development of myeloid-derived suppressor cells
Nevin, J. T., Moussa, M. R., Corwin, W. L., Măndoiu, I., & Srivastava, P. K. (2020) · Science Immunology · doi:10.1126/sciimmunol.aay9368 · Cited by 48
Bystander CD4 + T cells infiltrate human tumors and are phenotypically distinct
Li, S., Zhuang, S., Heit, A., Koo, S., Tan, A. C., Chow, I., Kwok, W. W., Tan, I. B., Tan, D. S. W., Simoni, Y., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2012961 · Cited by 48
Reactive oxygen species formation and its effect on CD4+ T cell-mediated inflammation
Shu, P., Liang, H., Zhang, J., Lin, Y., Chen, W., & Zhang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199233 · Cited by 58
Treg cell: Critical role of regulatory T-cells in depression
Gao, X. W., Tang, Y., Kong, L., Fan, Y., Wang, C., & Wang, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106893 · Cited by 51
Revisiting PD-1/PD-L pathway in T and B cell response: Beyond immunosuppression
Lu, J., Wu, J., Mao, L., Xu, H., & Wang, S. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.07.003 · Cited by 51
Pan, Y., Yang, W., Tang, B., Wang, X., Zhang, Q., Li, W., & Li, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1192303 · Cited by 53
Motwani, K., Peters, L. D., Vliegen, W. H., Elsayed, A. G., Seay, H. R., López, M. C., Baker, H. V., Posgai, A. L., Brusko, M., Perry, D. J., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00611 · Cited by 50
Deng, S., Chen, Y., Song, B., Wang, H., Huang, S., Wu, K., & Chu, Q. (2025) · Journal of Hematology & Oncology · doi:10.1186/s13045-025-01754-7 · Cited by 54
Wei, J., Yao, J., Yang, C., Mao, Y., Zhu, D., Xie, Y., Liu, P., Yan, M., Ren, L., Lin, Y., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03778-w · Cited by 48
FoxP3 in Treg cell biology: a molecular and structural perspective
Deng, G., Song, X., & Greene, M. I. (2019) · Clinical & Experimental Immunology · doi:10.1111/cei.13357 · Cited by 50
A theoretical framework of immune cell phenotypic classification and discovery
Hu, Y., Liu, C., Han, W., & Wang, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128423 · Cited by 46
Regulatory T cells in autoimmune kidney diseases and transplantation
Mikami, N., & Sakaguchi, S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00733-w · Cited by 46
Self-citationGut microbiota determines the fate of dietary fiber-targeted interventions in host health
Wang, W., Fan, Z., Yan, Q., Pan, T., Luo, J., Wei, Y., Li, B., Fang, Z., & Lu, W. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2416915 · Cited by 47
Developmental bifurcation of human T follicular regulatory cells
Kumar, S., Fonseca, V. R., Ribeiro, F., Basto, A. P., Agua‐Doce, A., Monteiro, M., Elessa, D., Miragaia, R. J., Gomes, T., Piaggio, E., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abd8411 · Cited by 47
The Coevolution of Placentation and Cancer
Wagner, G. P., Gupta, K., Dighe, A., & Levchenko, A. (2021) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020420-031544 · Cited by 45
T cell optimization for graft-versus-leukemia responses
Biernacki, M. A., Sheth, V., & Bleakley, M. (2020) · JCI Insight · doi:10.1172/jci.insight.134939 · Cited by 45
Phenotypic and Functional Diversity in Regulatory T Cells
Sjaastad, L. E., Owen, D. L., Tracy, S. I., & Farrar, M. A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.715901 · Cited by 50
Emery, A., Moore, S. E., Turner, J. E., & Campbell, J. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.788113 · Cited by 49
NETosis : Sculpting tumor metastasis and immunotherapy
Hu, Y., Wang, H., & Liu, Y. (2023) · Immunological Reviews · doi:10.1111/imr.13277 · Cited by 43
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
Takeuchi, Y., Hirota, K., & Sakaguchi, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01989 · Cited by 44
Self-citationRole of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Cho, H. J., & Cheong, J. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158011 · Cited by 51
Sustained Antitumor Immunity Based on Persistent Luminescence Nanoparticles for Cancer Immunotherapy
Wang, R., Shi, J., Song, L., Zheng, S., Liu, X., Hong, M., & Zhang, Y. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202106884 · Cited by 44
Mesenchymal Stem Cell Immunomodulation: A Novel Intervention Mechanism in Cardiovascular Disease
Wang, Y., Qi, Z., Yan, Z., Ji, N., Yang, X., Gao, D., Hu, L., Lv, H., Zhang, J., & Li, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.742088 · Cited by 46
Swatler, J., Turos-Korgul, L., Brewińska‐Olchowik, M., Biasi, S. D., Dudka, W., Le, B. V., Kominek, A., Cyranowski, S., Pilanc, P., Mohammadi, E., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006195 · Cited by 43
Ferreira, R. C., Dopico, X. C., de Oliveira, J. J., Rainbow, D. B., Yang, J. H. M., Trzupek, D., Todd, S. A., McNeill, M., Steri, M., Orrù, V., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02606 · Cited by 43
Reprogramming Immune Cells for Enhanced Cancer Immunotherapy: Targets and Strategies
Dong, Y., Wan, Z., Gao, X., Yang, G., & Liu, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.609762 · Cited by 44
Unraveling the Heterogeneity and Ontogeny of Dendritic Cells Using Single-Cell RNA Sequencing
Chen, B., Zhu, L., Yang, S., & Su, W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.711329 · Cited by 43
Regulatory T cells in gastric cancer: Key controllers from pathogenesis to therapy
Negură, I., Tanasa, M. P., & Danciu, M. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102629 · Cited by 44
Campos‐Mora, M., Solminihac, J. D., Rojas, C., Padilla, C. R., Kurte, M., Pacheco, R., Kaehne, T., Wyneken, Ú., & Pino‐Lagos, K. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12237 · Cited by 42
Cao, P., Sun, Z., Zhang, F., Zhang, J., Xiang, Z., Yu, B., Zhao, Y. X., Wang, W., & Wang, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.919674 · Cited by 41
The relationship between TIGIT+ regulatory T cells and autoimmune disease
Lee, D. J. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106378 · Cited by 43
Role of T cells in the pathogenesis and treatment of gout
Wang, B., Chen, S., Qian, H., Zheng, Q., Chen, R., Liu, Y., & Shi, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106877 · Cited by 41
Systematic review of the immunological landscape of Wilms tumors
Palmisani, F., Kovar, H., Kager, L., Amann, G., Metzelder, M. L., & Bergmann, M. M. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.06.016 · Cited by 40
Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
Hefazi, M., Bolivar-Wagers, S., & Blazar, B. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189676 · Cited by 40
Zhang, H., Shi, Y., Lin, C., He, C., Wang, S., Li, Q., Sun, Y. P., & Li, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1338918 · Cited by 40
Pinard, C., Debled, M., Rejeb, H. B., Velasco, V., de Lara, C. T., Hoppe, S., Richard, É., Brouste, V., Bonnefoi, H. R., & MacGrogan, G. M. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05437-z · Cited by 40
Liu, X., Cao, Y., Li, R., Gu, Y., Chen, Y., Qi, Y., Lv, K., Wang, J., Yu, K., Lin, C., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.01.002 · Cited by 39
Multiple Sclerosis: Lipids, Lymphocytes, and Vitamin D
Hayes, C. E., & Ntambi, J. M. (2020) · Immunometabolism · doi:10.20900/immunometab20200019 · Cited by 41
Pang, W., Jiang, Y., Li, A., Zhang, J., Chen, M., Li, H., Li, Z., & Wang, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.620943 · Cited by 39
Tolerogenic Nanovaccine for Prevention and Treatment of Autoimmune Encephalomyelitis
Park, J.-W., Le, Q., Wu, Y., Lee, J., & Oh, Y. (2022) · Advanced Materials · doi:10.1002/adma.202202670 · Cited by 39
Petrara, M. R., Bonfante, F., Costenaro, P., Cantarutti, A., Carmona, F., Ruffoni, E., Chiara, C. D., Zanchetta, M., Barzon, L., Donà, D., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.741796 · Cited by 41
Chemokine Receptor-Targeted Therapies: Special Case for CCR8
Moser, B. (2022) · Cancers · doi:10.3390/cancers14030511 · Cited by 41
Regulatory T Cells: Angels or Demons in the Pathophysiology of Sepsis?
Gao, Y., Yao, Y., Zhang, X., Chen, F., Meng, X.-L., Chen, X., Wang, C.-L., Liu, Y., Tian, X., Shou, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829210 · Cited by 40
Huang, M., Wang, T., Huang, Y., Wang, Y., Wu, S., Wang, F. Y., Tang, G., Wei, W., Liu, W., & Hou, H. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109262 · Cited by 38
Dissecting the roles and clinical potential of YY1 in the tumor microenvironment
Li, M., Wei, J., Xue, C., Zhou, X., Chen, S., Zheng, L., Duan, Y., Deng, H., Xiong, W., Tang, F., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1122110 · Cited by 39
Chen, C.-N., Hajji, N., Yeh, F., Rahman, S., Ali, S., Wharton, J., Baxan, N., Zhao, L., Xie, C.-Y., Chen, Y.-G., et al. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202301-0181oc · Cited by 38
Yu, H., Xue, W., Yu, H., Song, Y., Liu, X., Qin, L., Wang, S., Bao, H. F., Gu, H., Chen, G., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.171417 · Cited by 38
de Macedo, C. S., Lara, F. A., Pinheiro, R. O., Schmitz, V., Berrêdo‐Pinho, M., Pereira, G. M. B., & Pessolani, M. C. V. (2020) · F1000Research · doi:10.12688/f1000research.21383.1 · Cited by 38
Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections
Ciurkiewicz, M., Herder, V., & Beineke, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051705 · Cited by 38
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
Swatler, J., Turos-Korgul, L., Kozłowska, E., & Piwocka, K. (2021) · Cancers · doi:10.3390/cancers13061203 · Cited by 38
Wu, Q., Pan, C., Zhou, Y., Wang, S., Xie, L., Zhou, W., Ding, L., Chen, T., Qian, J., Su, R., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000320 · Cited by 37
Targeting T Cell Activation in Immuno-Oncology
Saibil, S. D., & Ohashi, P. S. (2020) · Current Oncology · doi:10.3747/co.27.5285 · Cited by 39
Evoking pyroptosis with nanomaterials for cancer immunotherapy: Current boom and novel outlook
Sun, Z., & Wang, W.-D. (2022) · Nano TransMed · doi:10.26599/ntm.2022.9130001 · Cited by 36
Denize, T., Jegede, O. A., Matar, S., Ahmar, N. E., West, D. J., Walton, E., Bagheri, A. S., Savla, V., Laimon, Y. N., Gupta, S., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2274 · Cited by 36
The role of regulatory T-cells in the development of endometriosis
Knez, J., Kovačič, B., & Goropevšek, A. (2024) · Human Reproduction · doi:10.1093/humrep/deae103 · Cited by 36
Hou, J., & Sun, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00723 · Cited by 38
Kroemer, M., Turco, C., Spehner, L., Viot, J., Idirène, I., Bouard, A., Renaude, E., Deschamps, M., Godet, Y., Adotévi, O., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001478 · Cited by 37
Zhang, J., Pan, S., Chen, J., Li, H., Dong, J., Sun, Q., Jin, H., & Han, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.819405 · Cited by 39
Wu, Q., Zhang, W., Wang, Y., Min, Q., Zhang, H., Dong, D., & Zhan, Q. (2021) · 癌症:英文版 · doi:10.1002/cac2.12203 · Cited by 35
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome
Xue, X., Li, R., Chen, Z., Li, G., Liu, B., Guo, S., Yue, Q., Yang, S., Xie, L., Zhang, Y., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1235827 · Cited by 37
RAS signaling and immune cells: a sinister crosstalk in the tumor microenvironment
Liu, Y., Xie, B., & Chen, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04486-9 · Cited by 36
Knoedler, L., Dean, J., Diatta, F. H., Thompson, N. T., Knoedler, S. A., Rhys, R., Sherwani, K., Ettl, T., Mayer, S. A., Falkner, F., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1372862 · Cited by 35
The Versatility of Sirtuin-1 in Endocrinology and Immunology
Rasha, F. A., Mims, B. M., Castro‐Piedras, I., Barnes, B. J., Grisham, M. B., Rahman, R. L., & Pruitt, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.589016 · Cited by 35
AKT1/FOXP3 axis-mediated expression of CerS6 promotes p53 mutant pancreatic tumorigenesis
Qi, D., Song, X., Xue, C., Yao, W., Shen, P., Yu, H. T., & Zhang, Z. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.06.024 · Cited by 35
Jiang, M., Liu, J., Yang, D., Tross, D., Li, P., Chen, F., Alam, M. M., Faustman, D. L., Oppenheim, J. J., & Chen, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108345 · Cited by 35
Th1-Like Treg Cells Are Increased But Deficient in Function in Rheumatoid Arthritis
Zhang, R., Miao, J., Zhang, K., Zhang, B., Luo, X., Sun, H., Zheng, Z., & Zhu, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.863753 · Cited by 35
Ren, H., Chen, Y., Zhu, Z., Xia, J., Liu, S., Hu, Y., Qin, X., Zhang, L., Ding, Y., Xia, S., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05879-w · Cited by 34
Zhang, W., Lu, C., Cai, S., Feng, Y., Shan, J., & Di, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.870282 · Cited by 34
Targeting regulatory T cells in gastric cancer: Pathogenesis, immunotherapy, and prognosis
Wang, B., Zhang, Z., Liu, W., & Tan, B. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114180 · Cited by 38
Malviya, M., Saoudi, A., Bauer, J., Fillatreau, S., & Liblau, R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102401 · Cited by 35
Control of regulatory T cell homeostasis
Buszko, M., & Shevach, E. M. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.07.001 · Cited by 33
Immunoregulatory Cells in Myasthenia Gravis
Wu, Y., Luo, J., & Garden, O. A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.593431 · Cited by 33
New insights for regulatory T cell in lupus nephritis
Li, Y., Tang, D., Yin, L., & Dai, Y. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103134 · Cited by 33
Novel potential therapeutic targets of alopecia areata
Xu, W., Wan, S., Xie, B., & Song, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148359 · Cited by 34
Nagira, Y., Nagira, M., Nagai, R., Nogami, W., Hirata, M., Ueyama, A., Yoshida, T., Yoshikawa, M., Shinonome, S., Yoshida, H., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0570 · Cited by 32
Why Treg should be the focus of cancer immunotherapy: The latest thought
Liu, Z., Zhou, J., Shi-hui, W., Chen, Z., Wu, S., Chen, L., Zhu, X. M., & Li, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115142 · Cited by 35
Immune regulation and therapeutic application of T regulatory cells in liver diseases
Ajith, A., Merimi, M., Arki, M. K., Hossein‐Khannazer, N., Najar, M., Vosough, M., Sokal, E. M., & Najimi, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1371089 · Cited by 32
T cells in cancer: mechanistic insights and therapeutic advances
Pu, J., Liu, T., Zhou, Y., Chen, M., Fu, X., Wan, Y., Wang, J., Chen, B., Sharma, A., Lukacs‐Kornek, V., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00807-w · Cited by 33
Rodríguez, N., Morer, Á., González‐Navarro, E. A., Serra‐Pages, C., Boloc, D., Torres, T., Martínez-Pinteño, A., Mas, S., Lafuente, A., Gassó, P., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.07.022 · Cited by 33
Vyas, S., Hansda, A. K., Kaplan, M. H., & Goswami, R. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901205 · Cited by 32
The thymus and the science of self
Geenen, V. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-020-00831-y · Cited by 23
Immunobiology of Gestational Diabetes Mellitus in Post-Medawar Era
Sharma, S., Banerjee, S., Krueger, P. M., & Blois, S. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.758267 · Cited by 34
Jiang, Z., Zhu, H., Wang, P., Que, W., Zhong, L., Li, X., & Du, F. (2022) · MedComm · doi:10.1002/mco2.137 · Cited by 35
Therapeutic Targeting of Tumor-Infiltrating Regulatory T Cells in Breast Cancer
Fattori, S., Roux, H., Connen, E., Robert, L., Gorvel, L., Roy, A. L., Houacine, J., Foussat, A., Chrétien, A.-S., & Olive, D. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0654 · Cited by 36
Macrophage-derived exosome promotes regulatory T cell differentiation in malignant pleural effusion
Shao, M., Pei, X., Chen, Q., Wang, F., Wang, Z., & Zhai, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1161375 · Cited by 34
Deng, S., Jin, P., Liu, S., Huang, L., Sherchan, P., Cui, Y., Zhang, J. H., Gong, Y., & Tang, J. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114451 · Cited by 30
Zhang, C., Li, Y., Yu, Y., Li, Z., Xu, X., Talifu, Z., Liu, W., Yang, D., Gao, F., Wei, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1334828 · Cited by 32
Zhang, W. (2021) · Purinergic Signalling · doi:10.1007/s11302-020-09761-8 · Cited by 31
Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics
Du, Y., Fang, Q., & Zheng, S. G. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_1 · Cited by 31
Zhao, L.-P., Hu, J.-H., Hu, D., Wang, H., Huang, C.-G., Luo, R., Huang, X., Huang, X., Xie, T., & Lou, J.-S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112949 · Cited by 34
Li, Z., Sun, Q., Liu, Q., Mu, X., Wang, H., Zhang, H., Qin, F., Wang, Q., Nie, D., Liu, A., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154475 · Cited by 31
Metadata
- Authors
- Wing, J. B., Tanaka, A., & Sakaguchi, S.
- Affiliations
- Immunology Frontier Research Center, The University of Osaka (JP)
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 50
- Issue
- 2
- Pages
- 302-316
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2917646500
- Cited by
- 726
- References
- 180
- Citations by year
- 2026: 55 · 2025: 95 · 2024: 117 · 2023: 120 · 2022: 114 · 2021: 105 · 2020: 87 · 2019: 33
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (16H06295, 18K07175)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- regulatory T cells, Foxp3, Treg differentiation, autoimmunity, tumor immunology, immune homeostasis, Treg therapy, single-cell analysis
- MeSH terms
- Animals, Cell Differentiation, Gene Expression Regulation, Humans, Neoplasms, Autoimmunity, T-Lymphocyte Subsets, Genetic Heterogeneity, T-Lymphocytes, Regulatory, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review